Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682769 · ClinicalTrials.gov registry record
Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 175
- Enrollment target
NCT04682769: Completed study, sponsored by Washington University School of Medicine.
NCT04682769 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04682769 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
Depression doubles the risk of death in patients with coronary heart disease (CHD), but so far, there is insufficient evidence that we can reduce the risk of death by treating depression. This study will investigate the cardiac risk markers that are associated with depression symptoms that remain despite treatment, and identify potential targets for their treatment. The results of the study will inform the development of more effective interventions to improve both depression and survival in patients with CHD.
Primary Outcome
Beck Depression Inventory (BDI-II) scale 0-63; higher score indicates a more severe depression
Interventions
- OTHER Other
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2025-05-31 |
What the finished NCT04682769 record still lists
NCT04682769 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Other is the first listed.
NCT04682769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04682769 about?
NCT04682769 is a clinical study titled "Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862". Depression doubles the risk of death in patients with coronary heart disease (CHD), but so far, there is insufficient evidence that we can reduce the risk of death by treating depression. This study will investigate the cardiac risk markers that are associated with depression symptoms that remain de...
What is the current status of trial NCT04682769?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2020-12-01. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT04682769?
The interventions under investigation include: Other (OTHER).
Who is sponsoring clinical trial NCT04682769?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI